Completed PHASE3 INTERVENTIONAL 2-arm NCT00441350

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Phase III Study Evaluating the Efficacy and Safety of Olmesartan Medoxomil/Hydrochlorothiazide 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Patients With Essential Hypertension

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Conditions Hypertension

Interventions OM 40 OM/HCTZ 40/12.5

Updated 10 times since 2017 Last updated: Jul 8, 2021 Started: Jul 31, 2007 Primary completion: May 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00441350, this PHASE3 trial focuses on Hypertension and remains completed. Sponsored by Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company, it has been updated 10 times since 2007, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3

▶ Show 5 earlier versions

Sep 2021 — Dec 2022 [monthly]

Completed PHASE3
Jan 2021 — Sep 2021 [monthly]

Completed PHASE3
Jul 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Jul 2018 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Menarini Group

Data source: Menarini Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Ashkelon, Israel , Baia Mare, Romania , Ballerup Municipality, Denmark , Beersheba, Israel , Benátky nad Jizerou, Czechia , Berlin, Germany , Bialystok, Poland , Brodce, Czechia , Brăila, Romania and 55 more locations